๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Spiramycin does not potentiate quinine treatment of falciparum malaria in pregnancy

โœ Scribed by F Nosten; F ter Kuilei; Kyaw Lay Thwai; L Maelankirri; N.J White

Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
196 KB
Volume
87
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized comparison of mefloquine-arte
Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy
โœ Rose McGready; Alan Brockman; Thein Cho; Dju Cho; Michele van Vugt; Christine Lu ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 732 KB

Since no effective malaria prevention measures have been identified for pregnant women living on the western border of Thailand, prompt diagnosis and efficient treatment are paramount, although drug resistance in Plasmodium falciparum has narrowed the treatment options. An open randomized comparison

Low-dose quinine for treatment of Plasmo
Low-dose quinine for treatment of Plasmodium falciparum malaria in Guinea-Bissau
โœ Poul-Erik Kofoed; Francisco Lopes; Peter Johansson; Francisco Dias; Anita Sandst ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 393 KB

The recommended dose of 10 mg quinine/kg bodyweight 3 times a day for 7 days for treatment of malaria is so high that many patients experience cinchonism. We have earlier obtained good results with 7 days' treatment with 20 mg Quinimax/kg bodyweight divided into 2 daily doses. In order to identify t